Albert Einstein College of Medicine of Yeshiva University receives funds to expand stem cell research capabilities Albert Einstein University of Medicine of Yeshiva University has been awarded $10 million from the National Institutes of Wellness to expand its stem cell research features. The money will be utilized to create brand-new laboratories to be able to increase its already substantial bottom of stem cell investigators. This will be carried out under the auspices of the established Ruth L recently medical articles . And David S. Gottesman Institute for Stem Cell and Regenerative Medicine Study. The Gottesman Institute for Stem Regenerative and Cell Medicine Research will utilize the NIH support, issued under the American Recovery and Reinvestment Action, to renovate and modernize existing study space and expand the related stem cell core services for cell sorting and cell transplantation.
Today, the Ruth L. And David S. Gottesman Institute for Stem Cell and Regenerative Medication Study at Albert Einstein College of Medicine of Yeshiva University hosted its second Stem Cell Symposium, concentrating on cancers stem cells. Leading scientists from the U.S., Canada and Belgium discussed the latest developments in the field and highlighted the issues of translating this understanding into targeted cancer remedies. ‘These exceptional researchers are pioneers in the field and also have made tremendous contributions to our understanding of the biology of stem cells and cancer tumor,’ said Paul Frenette, M.D., director and chair of Einstein's Stem Cell professor and Institute of medication and of cell biology.